[HTML][HTML] Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive …
C Cicognola, S Janelidze, J Hertze… - Alzheimer's research & …, 2021 - Springer
Introduction Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
C Cicognola, S Janelidze, J Hertze… - … research & therapy, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.
C Cicognola, S Janelidze, J Hertze… - Alzheimer's …, 2021 - search.ebscohost.com
Introduction: Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.
C Cicognola, S Janelidze, J Hertze… - … Research & Therapy, 2021 - go.gale.com
Introduction Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
C Cicognola, S Janelidze, J Hertze… - Alzheimer's …, 2021 - search.proquest.com
Method One hundred sixty MCI patients were followed for 4.7 years (average). AD pathology
was defined using cerebrospinal fluid (CSF) Aβ42/40 and Aβ42/total tau (T-tau). Plasma …
was defined using cerebrospinal fluid (CSF) Aβ42/40 and Aβ42/total tau (T-tau). Plasma …
[引用][C] Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
C Cicognola, S Janelidze, J Hertze… - … Research & Therapy …, 2021 - jglobal.jst.go.jp
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future
conversion to Alzheimer dementia in patients with mild cognitive impairment | Article …
conversion to Alzheimer dementia in patients with mild cognitive impairment | Article …
Plasma Glial Fibrillary Acidic Protein Detects Alzheimer Pathology and Predicts Future Conversion to Alzheimer Dementia in Patients With Mild Cognitive Impairment
C Cicognola, S Janelidze, J Hertze, H Zetterberg… - 2020 - researchsquare.com
Method 160 MCI patients were followed for 4.7 years (average). AD pathology was defined
using cerebrospinal fluid (CSF) Aβ42/40 and Aβ42/total tau. Plasma GFAP was measured at …
using cerebrospinal fluid (CSF) Aβ42/40 and Aβ42/total tau. Plasma GFAP was measured at …
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
C Cicognola, S Janelidze, J Hertze… - Alzheimer's …, 2021 - portal.research.lu.se
Introduction: Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
[PDF][PDF] Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
C Cicognola, S Janelidze, J Hertze, H Zetterberg… - 2021 - m.csc-mhw.com
Introduction: Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
and astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease …
[HTML][HTML] Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive …
C Cicognola, S Janelidze, J Hertze… - Alzheimer's …, 2021 - alzres.biomedcentral.com
Plasma glial fibrillary acidic protein (GFAP) is a marker of astroglial activation and
astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease (AD) …
astrocytosis. We assessed the ability of plasma GFAP to detect Alzheimer's disease (AD) …